Vascular involvement in cardiac giant cell myocarditis: A new pathophysiological aspect

Clinical Research in Cardiology

Volumn 103, Issue 2, 2014, Pages 161-163

  Elezkurtaj, S ^a   Lassner, D ^b   Schultheiss, H P ^a   Escher, F ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Institute of Cardiac Diagnostics and Therapy   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CORONARY VESSELS; FEMALE; GENE EXPRESSION REGULATION; GIANT CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; RNA, MESSENGER; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 84893845850     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-013-0638-2     Document Type: Letter

References (11)

1. Cooper LT Jr, Berry GJ, Shabetai R (1997) Idiopathic giant-cell myocarditis-natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. N Engl J Med 336:1860-1866 (Pubitemid 27263973)
2. Di Bella G, Florian A, Oreto L, Napolitano C, Todaro MC, Donato R, Calamelli S, Camastra GS, Zito C, Carerj S, Bogaert J, Oreto G (2012) Electrocardiographic findings and myocardial damage in acute myocarditis detected by cardiac magnetic resonance. Clin Res Cardiol 101:617-624
3. Frustaci A, Chimenti C, Pieroni M, Gentiloni N (2000) Giant cell myocarditis responding to immunosuppressive therapy. Chest 117:905-907 (Pubitemid 30152241)
4. Cooper LT Jr, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC et al (2008) Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol 102:1535-1539
5. Caforio AL, Calabrese F, Angelini A, Tona F, Vinci A, Bottaro S et al (2007) A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J 28:1326-1333 (Pubitemid 47355977)
6. Escher F, Westermann D, Gaub R, Pronk J, Bock T, Al-Saadi N et al (2011) Development of diastolic heart failure in a 6-year follow-up study in patients after acute myocarditis. Heart 97:709-714
7. Piggott K, Biousse V, Newman NJ, Goronzy JJ, Weyand CM (2009) Vascular damage in giant cell arteritis. Autoimmunity 42:596-604
8. Deng J, Ma-Krupa W, Gewirtz AT, Younge BR, Goronzy JJ, Weyand CM (2009) Toll-like receptors 4 and 5 induce distinct types of vasculitis. Circ Res 104:488-495
9. Alvarez Rodriguez L, Lopez-Hoyos M, Mata C, Fontalba A, Calvo Alen J, Marin MJ et al (2011) Expression and function of toll-like receptors in peripheral blood mononuclear cells of patients with polymyalgia rheumatica and giant cell arteritis. Ann Rheum Dis 70:1677-1683
10. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM (2008) Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation 118:1276-1284
11. Reinhard W, Kallmuenzer B, Bergua A, Fleck M, Luchner A, Riegger G, Fredersdorf S (2011) Reversible complete heart block in ANCA-associated vasculitis. Clin Res Cardiol 100:93-95